We previously described a signaling center, the Frontonasal Ectodermal Zone (FEZ) that regulates growth and patterning of the frontonasal process (FNP). The FEZ is comprised of FNP ectoderm flanking a boundary between Sonic hedgehog (Shh) and Fibroblast growth factor 8 (Fgf8) expression domains. Our objective was to examine BMP signaling during formation of the FEZ. We blocked BMP signaling throughout the FNP prior to FEZ formation by infecting chick embryos at stage 10 (HH10) with a replication-competent avian retrovirus encoding the BMP antagonist Noggin. We assessed gene expression patterns in the FNP 72 h after infection (∼ HH22) and observed that Shh expression was reduced or absent. In the mesenchyme, we observed that Bmp2 transcripts were absent while the Bmp4 expression domain was expanded proximally. In addition to the molecular changes, infected embryos also exhibited facial malformations at 72 and 96 h after infection suggesting that the FEZ did not form. Our data indicate that reduced cell proliferation, but not apoptosis, in the mesenchyme contributed to the phenotype that we observed. Additionally, adding exogenous SHH into the mesenchyme of RCAS-Noggin-infected embryos did not restore Bmp2 and Bmp4 to a normal pattern of expression. These data indicate that BMP signaling mediates interactions between tissues in the FNP that regulate FEZ formation; and that the correct pattern of Bmp2 and Bmp4, but not Bmp7, expression in the FNP mesenchyme requires signaling by the BMP pathway.
Introduction
Formation of the vertebrate face occurs through integrated development of distinct facial primordia. The upper and lower jaws are derived from the mandibular, maxillary, and frontonasal processes (FNP) , and the tongue is derived from the hyoid processes. Our previous research has focused on development of the frontonasal and maxillary processes (Cordero et al., 2004; Hu et al., 2003; Marcucio et al., 2005) . Within the FNP two types of mesenchymal cells are present. The neural crest cells will give rise to the connective tissues, and the mesoderm will give rise to the endothelium of the vascular network (Couly and Douarin, 1988; Evans and Noden, 2006) . These mesenchymal cells are bounded by epithelia derived from the forebrain and the facial ectoderm, and development of the middle and upper face is regulated by a series of signaling interactions among the forebrain, the mesenchyme, and the facial ectoderm (Eberhart et al., 2006; Gunhaga et al., 2000; Hu et al., 2003; Marcucio et al., 2005; Martinez-Barbera et al., 2001; Niederreither et al., 1999; Schneider et al., 2001; Shigetani et al., 2000; Wada et al., 2005; Ye et al., 1998) .
The ectoderm of the FNP regulates development of the upper beak of birds (Hu et al., 2003) . Sonic hedgehog (Shh) and Fibroblast Growth Factor-8 (Fgf8)-expressing cells form a boundary in the ectoderm of the FNP that corresponds to the distal tip of the upper beak (Hu et al., 2003) . Transplantation of the ectoderm flanking this boundary induced the formation of ectopic upper beak structures that reflected the dorsoventral polarity of the grafted tissue (Hu et al., 2003) . Furthermore, inhibiting formation of this boundary led to truncations of the Available online at www.sciencedirect.com Developmental Biology 312 (2007) 103 -114 www.elsevier.com/developmentalbiology upper jaw (Cordero et al., 2004; Marcucio et al., 2005) . Collectively, these data suggest that this signaling center, which we named the Frontonasal Ectodermal Zone (FEZ), coordinates patterned outgrowth of the FNP. The specific role of FGF8 and SHH in mediating FEZ function is not known. FGF8 is required for initial FEZ activity (Hu et al., 2003) , but data indicate that Fgf8 needs to be downregulated for normal development of the FNP (MacDonald et al., 2004) . In contrast Shh expression in the FEZ appears to be required for FNP outgrowth (Cordero et al., 2004; Marcucio et al., 2005) and ectopic SHH promotes expansion of the FNP (Hu and Helms, 1999) . Finally, signaling by the combination of FGF8 and SHH induced ectopic cartilage outgrowths in the head of chick embryos . These results suggest that SHH signaling may be essential for the FEZ to function. However, mechanisms that regulate formation of this signaling center and the identities of the molecular mediators and targets of FEZ activity are unknown.
Bone morphogenetic proteins (BMPs) are important for development of the face. There is clear evidence that signaling by BMPs is essential for development of the axial and appendicular skeleton (reviewed in Yoon and Lyons, 2004) . However, BMP signaling also regulates many aspects of morphogenesis. Variations in BMP signaling created morphological diversification that reflected species-specific form of the middle and upper face Wu et al., 2004) . Furthermore, modulating BMP signaling within the maxillary process exerted a profound influence on morphology of the maxillary derivatives; blocking BMP signaling while stimulating the retinoid pathway led to a conversion of the maxillary process to a structure that resembled a duplicated FNP (Lee et al., 2001) . The importance of BMP signaling to FNP development Wu et al., 2004) , regulation of Bmp2 expression by SHH signaling (Hu and Helms, 1999) , and the expression patterns of Bmps within the FNP (Francis-West et al., 1994) has led us to initiate a series of experiments designed to examine the effects of BMP signaling within the FNP. We blocked BMP signaling in the FNP of avian embryos prior to the arrival of neural crest cells and then examined the resulting molecular and morphological alterations.
Results
The FEZ is a putative target of BMP signaling Our initial step in assessing the role of BMP signaling during development of the FNP was to determine the cellular targets of BMP signaling prior to and immediately after FEZ formation. As neural crest cells migrate into the FNP, Shh expression is induced within the stomodeal ectoderm (Marcucio et al., 2005) . Prior to the onset of Shh expression at HH20 (Cordero et al., 2004; Marcucio et al., 2005) , BMP receptor Type R1b (BmpR1b) is expressed in the facial ectoderm (HH15; Fig. 1A ) and mesenchyme (HH17; Fig. 1B ) within the FNP. Similarly BMP receptor Type R1a (BmpR1a) is expressed throughout the FNP (HH15 and HH17; Figs. 1D, E, respectively). At HH22, after outgrowth of the FNP has begun, expression of BmpR1b and BmpR1a exhibits widespread expression in the facial mesenchyme and the brain ectoderm (Figs. 1C, F) . These data suggest that ectodermal cells comprising the FEZ are targets of BMP signaling prior to FEZ formation and indicate that the targets of BMP signaling may change rapidly during the early stages of development of the FNP.
Blocking BMP signaling prevents formation of the FEZ Since tissue comprising the FEZ is a likely target of BMP signaling, our next objective was to examine the effect of blocking BMP signaling on development of the FNP. We infected the neural crest cells migrating to the frontonasal process with a replication-competent retrovirus encoding the BMP antagonist Noggin (RCAS-Noggin) by injecting the virus into the mesenchyme adjacent to the forebrain of HH10 embryos (Fig. S1 ). Embryos were infected at this time, because the neural tube has closed, and neural crest cells have emigrated from the forebrain and midbrain (Tosney, 1982) and were moving into the FNP. Thus, generation of neural crest cells was not altered by our treatment.
Fgf8 and Shh are key components of the FEZ Hu et al., 2003) . Therefore, our first objective was to identify changes in the pattern of expression of these genes before (48 h after infection, ∼HH18) and after (72 h after infection, ∼ HH22) FEZ formation in embryos infected with RCAS-Noggin. Blocking BMP signaling did not alter the downregulation of Fgf8 expression in most of the embryos (n = 7/10; data not shown). At HH22, Fgf8 is normally down-regulated in the midline of the FNP but a few embryos (n = 3/10) exhibited a small area of Fgf8-expressing cells located in the ectoderm below the optic recess (Fig. 2E) . We found that Shh expression was altered by RCAS-Noggin treatment (n = 13/14). In embryos examined 72 h after infection with RCAS-Noggin (∼ HH22), Shh transcripts were either absent (n = 5/14; not shown) or the Shh expression domain was greatly reduced (n = 8/14; Fig. 2F ; see also Fig. 7C ) in the facial ectoderm compared to normal (Fig.  2B ) and control embryos (Fig. 2D) . Shh expression in the diencephalon and telencephalon was not altered in embryos infected with RCAS-Noggin. To ensure that the ectoderm destined to express Shh did not undergo apoptosis, we performed a TUNEL analysis at 48 h (∼HH18; n = 4 RCAS-Noggin, n = 4 RCAS-AP) and 72 h (∼ HH22; n = 3 RCAS-Noggin, n = 2 RCAS-AP) after infection with RCAS-Noggin. We observed no evidence of DNA fragmentation in any of the cells in the ectoderm of embryos infected with RCAS-Noggin (data not shown). To distinguish the effect of Noggin mis-expression in the FNP mesenchyme versus the stomodeal ectoderm, we infected the ectoderm in embryos beginning at HH14, because at this time the ectoderm covering the face is easily targeted. We observed no alteration of the phenotype at HH22 (n = 4; data not shown). Together, these observations indicate that Noggin expression in the facial mesenchyme does not affect the timing of down-regulation of Fgf8 expression, but perturbs the induction sequence of Shh in the stomodeal ectoderm of the face. Thus, formation of the FEZ is disrupted when BMP signaling within the mesenchyme is blocked by Noggin. 
RCAS-Noggin inhibits BMP signaling pathway
We used multiple approaches to examine the extent to which BMP signaling was inhibited by the expression of Noggin. First we analyzed the expression of Msx1 and Msx2, which are known to be activated by the BMP signaling pathway (Barlow and Francis-West, 1997 ) among others (Hussein et al., 2003; Tan et al., 2002) . No difference in Msx1 and Msx2 expression was observed between treated and control embryos (Fig. S2) . To ensure that the BMP pathway was blocked, we used an in vivo functional assay that is based on the necessity of BMP signaling for skeletal formation (reviewed in Yoon and Lyons, 2004; Wan and Cao, 2005) . Since infecting embryos at HH10 leads to death between HH26 and HH30, which is prior to skeletal development, we infected the right mandibular primoridium of embryos at HH22 with the RCAS-Noggin virions. At 13 days of incubation, we observed an absence of bone and cartilage on the treated compared to the control side. Specifically, the mandibular cartilage and the adjacent bones were missing (Fig. 3 ). This result indicates that RCAS-Noggin infection was able to inhibit the BMP signaling pathway to a degree that completely abrogated skeletal development.
Malformations in embryos infected with RCAS-Noggin suggest FEZ inactivity
Our gene expression data indicate that the FEZ does not form properly when BMP signaling is blocked. A gross morphological analysis of RCAS-Noggin-infected embryos (RCASNoggin, n = 55; RCAS-AP, n = 30; Normal, n = 45) revealed that blocking BMP signaling prior to FEZ formation created severe FNP malformations (Fig. 4G ). The progression of the phenotype was directly related to the extent of retroviral infection. At 24 h post-infection (∼ HH14), no obvious malformations were evident (RCAS-Noggin, n = 6; RCAS-AP, n = 4; Normal, n = 4), and neural crest cells had not arrived in In embryos infected with RCAS-Noggin, Fgf8 transcripts exhibited normal pattern of expression (n = 7/10). In rare cases (n = 3/10), a few cells expressing Fgf8 were detected in the ectoderm below the optic recess (yellow arrowhead). (F) In the brain of embryos infected with RCASNoggin, Shh expression at HH22 is normal. However, in the facial ectoderm, the Shh expression domain was either reduced (n = 8/14) or Shh transcripts were absent (n = 5/14). te, telencephalon; or, optic recess; di, diencephalon; fe, facial ectoderm; ma, mandible; Scale bar: 500 μm.
the FNP yet (data not shown). By 48 h (∼ HH18; RCAS-Noggin, n = 10; RCAS-AP, n = 7; Normal, n = 8), embryos infected with RCAS-Noggin exhibited altered development of the maxillary and mandibular processes, but the FNP appeared unaltered ( Fig. S3 ). At this time, the maxillary and mandibular processes were small and FNP outgrowth had not begun. In these embryos, widespread expression of vENV ( Fig. S3 ) and Noggin ( Fig. S3 ) was evident throughout the head. By 72 h (∼ HH22; RCASNoggin, n = 25; RCAS-AP, n = 14; Normal, n = 22) and 96 h (∼HH26; RCAS-Noggin, n = 14; RCAS-AP, n = 5; Normal, n = 11), the malformations were very severe, and retroviral infection was widespread (Fig. 4) . The maxillary processes were rudimentary, the eyes were rotated forward, the FNP exhibited no signs of proximodistal extension, and the nasal pits were small. At 72 h (∼ HH22), the facial mesenchyme of RCASNoggin treated embryos was abundant and was comprised of a large number of cells (e.g., Figs. 4H, Q). Other embryos were allowed to develop to later stages in order to examine the impact of NOGGIN on formation of the skeletal elements of the upper beak. The malformations were severe at 96 h post-infection (∼ HH26; Figs. 4J-R). Unfortunately, we were unable to analyze later developmental events in infected embryos, because most embryos died between 96 and 120 h post-infection. Only 2 embryos survived for 6 days after infection (8 days total development), and an analysis of the skeleton of the face could not be performed.
We next sought to determine whether changes in cell proliferation within the FNP could have contributed to the phenotype that we observed. We analyzed BrdU incorporation 48 h (∼ HH18) and 72 h (∼ HH22) after infection with RCAS-Noggin. We observed no significant difference in the proportion of proliferating cells within the facial mesenchyme at 48 h after infection (∼ HH18; ANOVA, p N 0.05, groups: Normal (n = 5) average = 27%, SD = 17%; RCAS-AP (n = 5) average = 31%, SD = 7.5%; RCAS-Noggin (n = 5) average = 25%, SD = 11%). However, we found a statistically significant reduction in the proportion of proliferating cells within the facial mesenchyme at 72 h after infection with RCAS-Noggin (∼ HH22; ANOVA, p b 0.05, groups: Normal (n = 3) average = 23.6%, SD = 12.3%; RCAS-AP (n = 4) average = 25%, SD = 5.8%; RCAS-Noggin (n = 3) average = 6.1%, SD = 3.9%). At this time, we did not detect significant changes in cell proliferation in the stomodeal ectoderm (ANOVA, p N 0.05, groups: Normal (n = 3) average = 5.2%, SD = 5.7%; RCAS-AP (n = 4) average = 8%, SD = 1.8%; RCAS-Noggin (n = 3) average = 4.2%, SD = 3.4%). We next analyzed the BrdU incorporation qualitatively at 96 h after infection (∼HH26; Fig. 5 ). Normally at this time a focal zone of proximodistal extension is evident in the FNP (Figs. 4K, N). However, in embryos infected with RCAS-Noggin, there was no evidence of this focal zone of growth (Fig. 4) . We observed an actively proliferating zone of growth in RCAS-AP control embryos (Figs. 5C, D) which was absent in RCASNoggin treated embryos (Figs. 5A, B) . We observed very few apoptotic cells in treated and control embryos at ∼ HH18 or ∼ HH22, and we found no evidence that RCAS-Noggin infection increased cell death (data not shown). Likewise, at ∼HH26 we observed no apoptosis within the region depicted in Fig. 5 (data not shown) . Thus, blockade of BMP signaling inhibited the formation of the growth zone within the FNP by decreasing cell proliferation, but did not increase cell death.
Over-expression of Noggin in the FNP alters Bmp2 and Bmp4 expression patterns
Our previous data indicated that the FEZ directs gene expression in the underlying mesenchyme (e.g., Hu et al., 2003) . In this investigation, we compared the expression patterns of Bmp2, Bmp4, and Bmp7 at 72 h (∼ HH22) among embryos infected with RCAS-Noggin, RCAS-AP, and normal embryos, because these molecules are expressed within the mesenchyme and are important for development of the FNP . Bmp7 expression was unaffected by RCAS-Noggin treatment (Fig. 6H , n = 6/6) compared to untreated (Fig. 6B , n = 3/3), and control embryos (Fig. 6E , n = 7/7). However, we observed perturbations of the Bmp2 and Bmp4 expression domains. In normal embryos (Fig. 6A , n = 5/5) and RACS-APinfected embryos (Fig. 6D , n = 7/7) Bmp2 was expressed in mesenchyme adjacent to the diencephalon and in the epithelium of Rathke's pouch. In embryos infected with RCAS-Noggin (Fig. 6G , n = 8/8), Bmp2 transcripts were restricted to the proximal portion of Rathke's pouch, and Bmp2 was not expressed in the surrounding mesenchyme. Bmp4 transcripts are normally detected in the distal mesenchyme of the FNP at HH22 (Figs. 6C , n = 4/4 and 7F, n = 7/7). In embryos infected with RCAS-Noggin, the Bmp4 expression domain was expanded proximally and extended beneath the optic recess (Fig. 6I , n = 10/10). These perturbations in expression of Bmp2 and Bmp4 may be a direct consequence of blocking BMP signaling or could have resulted from disrupted signaling from the FEZ that formed in these embryos.
In our last experiment, we wanted to determine the effect of restoring SHH to the FNP on Bmp2 and Bmp4 expression. We first infected embryos with RCAS-Noggin as described, and then 48 h later at ∼ HH18, we restored SHH in the mesenchyme by implanting a bead soaked in the amino terminal portion of SHH protein (SHH-N; (Fig. 7A) . Twenty-four hours after bead implantation (∼HH22), we examined gene expression in the FNP. SHH signaling was evident by the widespread expression of the down-stream target, Patched (Ptc; Fig. 7B , n = 10/10), even though the endogenous domain of Shh was reduced (Fig.  7C , n = 10/10). In these embryos (Fig. 7F) , placement of SHH-N in the FNP was not able to restore the normal expression of Bmp4 and Bmp2 in the mesenchyme (Figs. 7D and E, respectively, n = 10/10).
Discussion
Blocking BMP signaling leads to facial malformations and alters gene expression Our goal was to determine whether BMP signaling is required for FEZ formation and FNP outgrowth. To achieve this we blocked BMP signaling by injecting a replication-competent avian retrovirus encoding Noggin into the mesenchyme adjacent to the forebrain of HH10 chick embryos. At this developmental stage, emigration of neural crest cells from the neural tube is complete. Propagation of the virus within the embryo led to widespread infection of the FNP crest within 48 h (∼ HH18). However, this also led to infection of more caudal populations of neural crest cells as well as the paraxial mesoderm populations of the head. Thus, the mandibular arch and mesodermal derivatives were infected by RCAS-Noggin.
Embryos infected with RCAS-Noggin had severe facial malformations. At HH22 and 26, we observed a phenotype characterized by lack of proximodistal extension of the FNP, rudimentary maxillary processes, small nasal pits, and forward rotation of the eyes. The phenotype that we observed was caused by reduced cell proliferation in the facial mesenchyme. These data indicate that BMP signaling does not regulate expansion of the ectoderm, but BMP signals regulate growth within the mesenchyme of the FNP. Furthermore, these changes indicate that the normal zone of proximo-distal extension within the FNP is regulated by BMP signaling. Our data agree with previously published reports illustrating the importance of BMP signaling during growth of the FNP Liu et al., 2005; Wu et al., 2006; Wu et al., 2004) . In addition to the alterations in cell proliferation in the mesenchyme, we also observed molecular changes in the FEZ and mesenchyme that likely contributed to the phenotype. Specifically, Shh expression was down-regulated in the FEZ, Bmp2 was down-regulated in the facial mesenchyme, and concomitantly the Bmp4 expression domain was expanded proximally. Lastly, our data demonstrate that when exogenous SHH protein was provided to the FNP mesenchyme, the normal patterns of BMP expression were not restored.
BMP signaling is required for development of a functional FEZ
Epithelial-mesenchymal interactions that regulate development of the upper jaw are controlled, in part, by the FEZ (Hu et al., 2003) . Our current data clearly demonstrate that BMP signaling regulates Shh expression in the FEZ. However, the mechanism underlying this regulation is not known. For instance, BMP signaling could directly activate transcription of the Shh locus in the FEZ. Alternatively, Shh expression could be regulated by a signaling molecule that is down stream of BMPs. We have already shown that SHH signaling within the forebrain is required for the onset of Shh expression within the FEZ, and that SHH does not appear to act directly on the FEZ to regulate Shh expression (Marcucio et al., 2005) . Instead, an undefined, SHH-dependent, signal from the brain is required. Collectively, these previous and our current data suggest that part of this signaling network includes BMPs. We are currently assessing the ability of various signaling pathways to restore Shh expression within these various embryos.
Could Shh expression be regulated by members of the TGF-β superfamily?
Control of Shh expression occurs via multiple mechanisms in both a tissue-and a time-specific manner through a complex series of transcriptional activators and repressors (e.g., Epstein et al., 1999) . However, to date no regulatory elements have been identified in or around the Shh locus that potentially regulate expression of Shh within the FEZ. In the limb bud, BMP signaling indirectly suppresses Shh expression in the Zone of Polarizing Activity by disrupting the positive feedback loop between FGF and SHH signaling (Pizette and Niswander, 1999) . In fact, normally the activity of the BMP antagonist Gremlin is required to suppress BMP signaling and maintain function of the Apical Ectodermal Ridge (Khokha et al., 2003) . Similarly, in the anterior portion of the head, increased BMP signaling correlates with reduced Shh expression (Anderson et al., 2002; Ohkubo et al., 2002) , and a balance of signaling among BMPs, SHH, and FGF8 is necessary for correct patterning and development of the forebrain (Ohkubo et al., 2002) . From these data, we would have predicted that blockade of BMP signaling in the FNP would have led to an increase of Shh expression as observed in the limb (Zuniga et al., 1999) .
Our current data demonstrate an opposite effect; BMP signaling appears to be required for Shh expression in the FEZ. There is no evidence that BMP signaling activates transcription of the Shh locus directly, but there is a precedent that the Shh locus can be activated by Smad signaling. Cyclops (Cyc), a member of the TGFβ superfamily of molecules, directly regulates Shh expression within the floor plate of the neural tube of zebrafish embryos (Muller et al., 2000) . Furthermore, signaling by BMP4 regulates expression of Shh expression in the dental (Chen et al., 1996) and the palatal (Zhang et al., 2002) epithelium in mice. In the mandible of chicken embryos, extension of the Shh expression domain within the ectoderm was observed after application of ectopic BMP proteins. This extension occurred in conjunction with an expansion of Msx expression domains. In these experiments, Msx genes were shown to be directly up-regulated by BMP signaling (Barlow and Francis-West, 1997) . However, in our experiments, we did not detect any noticeable changes in the expression patterns of Msx1 and Msx2, and this has been observed by others (Ashique et al., 2002) . In fact, activity of MSX1 appears to be, in part, upstream of Bmp4 expression in the mesenchyme of the developing mouse face, because transgenic expression of Bmp4 in the Msx1 −/− mouse is able to rescue the clefting defect (Zhang et al., 2002) . In addition, Msx2 expression is regulated in a BMPindependent manner through the activity of the transcription factor YY1 (Tan et al., 2002) which is expressed in the ectoderm covering the FNP (data not shown). Lastly, data indicate that signaling via the canonical Wnt pathway is also able to regulate expression of Msx genes (Hussein et al., 2003) . Thus, while MSX activity may mediate some components of BMP signaling, in the developing face the epithelial-mesenchymal interactions appear to be mediated by a genetic signaling network among various molecular pathways. BMPs, SHH, and MSX geneproducts may act to integrate these signaling networks.
Improper FEZ formation may result in changes in Bmp2 and Bmp4 expression
Our data demonstrate that BMP signaling is required for development of a functional FEZ. Embryos infected with RCAS-Noggin exhibited severe craniofacial malformations that are reminiscent of the absence of a functional FEZ (Cordero et al., 2004; Marcucio et al., 2005) . In addition to morphological changes, we observed changes in gene expression patterns in the FNP mesenchyme. The Bmp4 expression domain was extended proximally, and Bmp2 expression was restricted to the ectoderm adjacent to Rathke's pouch and absent from the surrounding mesenchyme. These changes could have resulted from either the blockade of BMP signaling or the reduced Shh expression in the FEZ or both. The ability of SHH signaling to govern expression of Bmp2 and/or Bmp4 had been demonstrated in the vertebrate limb bud (Laufer et al., 1994) , the hindgut (Roberts et al., 1995) , and in the face (Hu and Helms, 1999; Zhang et al., 2002) . Specifically, in the FNP of developing chick embryos, beads soaked in SHH-N induced Bmp2 expression in adjacent mesenchymal cells (Hu and Helms, 1999) . However, in our experiments, exogenous SHH protein in the mesenchyme was not able to restore the normal pattern of Bmp2 expression in presence of exogenous Noggin. Together these data seem to suggest that SHH may govern expression of Bmp2 in the facial mesenchyme in a BMP-dependent fashion.
Disruptions to BMP signaling create craniofacial malformations
Craniofacial malformations can occur as a result of disrupting BMP signaling. Mutations in the BMP antagonist Noggin result in facioaudiosymphalangism syndrome, which, among other skeletal defects, is characterized by broad hemicylindrical nose, and hypoplasia of alae nasi, long face, and ontological abnormalities (Declau et al., 2005; Obregon et al., 2000) . Morphologically, these changes agree with the results of our study that suggest increased BMP signaling would increase growth of the FNP. Another member of the BMP signaling pathway has also been implicated in human disease. Mutations in the SOST gene, which encodes sclerostin, a BMP antagonist and negative regulator of bone formation, result in sclerosteosis or Van Buchem disease (van Bezooijen et al., 2005) . These closely related disorders are characterized by progressive bone thickening resulting in craniotubular sclerosing dysplasia with associated facial and skeletal malformations (Balemans et al., 1999; Nager and Hamersma, 1986) .
While specific craniofacial malformations have been shown to result from mutations in BMP antagonists, our experiments reveal that interactions between SHH and BMP signaling pathways may be susceptible to teratogens. Craniofacial malformations are common and create substantial psychological burden on patients and their families. These birth defects arise as a result of genetic or environmental perturbations that disrupt developmental processes. For instance, genetic alterations or teratogens that disrupt cell and tissue interactions can have catastrophic effects. Mutations in the gene encoding Sonic hedgehog Roessler et al., 1996) or disruptions in SHH signaling by teratogens such as cyclopamine (Cordero et al., 2004; Coventry et al., 1998; Incardona et al., 1998; Keeler, 1973; Keeler, 1975; Keeler, 1978) , alcohol, or retinoids (Cohen and Shiota, 2002) can lead to holoprosencephaly (HPE). This condition is characterized by a spectrum of defects in forebrain and facial development (Roessler and Muenke, 1998) . The extreme form of HPE manifests as cyclopia (Cohen et al., 1971; Muenke and Beachy, 2000) and results from early disruption of Shh expression in the brain and face (Anderson et al., 2002; Cordero et al., 2004) . Microforms of HPE result in a single, central incisor, narrowing of the space between the eyes, and/or median cleft lip and palate (Muenke et al., 1994) , and these defects can arise from disruption to SHH signaling within the face itself (Cordero et al., 2004) . In addition to genetic mutations or molecules that disrupt the ability of SHH to bind to its receptor, mutations or molecules that disrupt the Shh induction sequence could also elicit defects of the brain and/or the face. For example, we have demonstrated that disruption of the Shh induction sequence at discrete times within the head creates the spectrum of defects that are associated with HPE (Cordero et al., 2004) . The data presented here suggest that BMP signaling regulates formation of the FEZ, and that members of the BMP pathway could be targets for teratogens that cause formes frustes of HPE.
Experimental procedures

Preparation of Noggin expressing avian virus (RCAS-Noggin)
Replication-competent avian sarcoma retroviral vector encoding chicken Noggin cDNA, alkaline phosphatase, or Shh (RCAS-Noggin, RCAS-AP or RCAS-Shh respectively) were produced as described (Fekete and Cepko, 1993) . Briefly, virus stocks were prepared by transfection of proviral DNA plasmid into immortalized chicken embryonic fibroblasts (DF-1 cells). Transfected DF-1 cells were expanded in Dulbecco's Minimum Essential Medium (DMEM) supplemented with 10% fetal bovine serum (FBS). After 2 passages, cells were grown under low serum conditions (1% FBS) and virions were harvested over 3 consecutive days from confluent cultures. Viral supernatants were concentrated by centrifugation at 25,000 rpm for 3 h at 4°C. After discarding the supernatants, viral pellets were re-suspended in low serum culture medium, and 10 μl aliquots were frozen at − 80°C.
Infection with RCAS-Noggin virus
Virus-dye solutions (10 μL of virus supplemented with 1 μl of 0.02% Fast Green) were prepared at the time of injection to allow visualization of injected solutions. A pulled borosilicate glass capillary pipette (OD = 1.0 mm; ID = 0.5 mm; Sutter Instrument, Novato, CA) connected to a KITE-R micromanipulator (World Precision Instruments Sarasota, FL) was loaded with the virus-dye solution. Embryos (SPAFAS) were incubated to HH10, HH14, or to HH22 and then a hole was made in the shell. A solution of neutral red was applied to the vitelline membrane to visualize the embryo. Injections were carried out using a PV830 Pneumatic Picopump (World Precision Instruments Sarasota, FL). Approximately 100-150 nl of virus-dye solution was injected into the mesenchyme on each side of the forebrain (see Fig. S1 for site of injection) of HH10 embryos. Viable embryos were euthanized and collected at 24, 48, 72, and 96 h post treatment. The stomodeal ectoderm of HH14 embryos was infected with RCAS-Noggin by injecting approximately 100-150 nl of virus-dye solution into the mouth. Embryos were euthanized and collected 48 h post treatment (∼ HH22). RCAS-Alkaline phosphatase (RCAS-AP) virus, similarly prepared, and was used to infect control embryos. To assess the ability of RCAS-Noggin to block skeletogenesis in the jaw, embryos were incubated to HH22 and the right side of the mandible was injected with RCAS-Noggin virions. Embryos were euthanized after 13 days of incubation.
SHH-N beads
Affi-gel blue beads (50-100 mesh, 200-250 μm diameter; Biorad) were soaked in recombinant SHH-N protein (800 μg/ml in PBS 0.1% bovine serum albumin (BSA) Ontogeny) for 1 h at 37°C; beads were implanted into the FNP of ∼HH18 embryos (Marcucio et al., 2005) . Embryos were collected after an additional 24 h of incubation (∼ HH22), and prepared for analysis of gene expression.
Embryo processing
Embryos were fixed in 4% paraformaldehyde at 4°C overnight, transferred to PBS containing 0.01% ethidium bromide, and photographed using a Leica MFLZIII dissecting microscope equipped with epifluorescent illumination. Embryos were then dehydrated and embedded in paraffin. Sections, 7 μm sagittal, were then prepared.
In situ hybridization
In situ hybridization was performed on paraffin wax embedded sections as previously described (Albrecht et al., 1997) . Subclones of v-ENV, Noggin, Shh, Fgf8, Bmp2, Bmp4, Bmp7, Msx1, Msx2, and Patched (Ptc) were linearized for transcription of 35 S-labeled antisense riboprobes.
Safranin O staining
Sections from day 13 embryos were stained with safranin O/Fast green (SO/ FG) to visualize cartilage (red) (Lu et al., 2006) .
BrdU labeling
Embryos were infected with RCAS-Noggin as described. Forty-eight, 72, or 96 h after infection and 20 min prior to collection, 200 nl of BrdU labeling reagent (Zymed, South San Francisco, CA) was injected into a blood vessel near the heart. Embryos were fixed, embedded, and sectioned as described. BrdU-labeled cells were visualized on paraffin sections; detection of BrdU incorporation was assessed by immunohistochemistry and detection with diaminobenzidine (DAB) followed by counterstaining all nuclei with hematoxylin following the manufacturer's instructions (Zymed). At 48 h after infection, the percentage of proliferating cells in medial and lateral sections was determined on images captured using Adobe Photoshop. At 72 h after infection, the percentage of proliferating cells in medial sections was similarly determined. Analysis of Variance (ANOVA) was performed on medial or lateral sections separately to determine statistical significance.
TUNEL analysis
DNA fragmentation was examined using a TUNEL kit following the manufacturer's instructions (Apoptag Plus, Intergen).
